Botox maker Allergan Inc, which is fending off an acquisition by Valeant Pharmaceuticals Inc , said on Monday that it had been approached by another party regarding a potential transaction.The company is Actavis Plc, a source familiar with the situation said.Allergan, which made the disclosure in a regulatory filing on Monday, had said it was looking for acquisitions but has not previously said it had been contacted about a deal.Valeant and Pershing Square Capital Management, which owns nearly a 10 percent stake in Allergan, made an offer now worth $55 billion for Allergan at the end of April.
Shares of ACT traded higher by 2.17% or $5.26/share to $248.00. In the past year, the shares have traded as low as $153.42 and as high as $249.94. On average, 2407010 shares of ACT exchange hands on a given day and today's volume is recorded at 1259400.
Allergan, Inc. is a multi-specialty health care Company focused on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter products. Shares of AGN traded higher by 0.89% or $1.69/share to $191.75. In the past year, the shares have traded as low as $88.34 and as high as $192.98. On average, 2403670 shares of AGN exchange hands on a given day and today's volume is recorded at 1907521.
Source
